Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of Decitabine in Patients With Chronic Myelomonocytic Leukemia

NCT01098084 is registered in ClinicalTrials.gov with Groupe Francophone des Myelodysplasies as lead sponsor.

NCT NCT01098084
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01098084 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of Decitabine in Patients With Chronic Myelomonocytic Leukemia
Lead sponsor
Groupe Francophone des Myelodysplasies
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2008
Completion date
June 30, 2009
Enrollment
41 (actual)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

chronic myelomonocytic leukemia